351 related articles for article (PubMed ID: 7903105)
1. Combined anti-CD2 and anti-CD3 receptor monoclonal antibodies induce donor-specific tolerance in a cardiac transplant model.
Chavin KD; Qin L; Lin J; Yagita H; Bromberg JS
J Immunol; 1993 Dec; 151(12):7249-59. PubMed ID: 7903105
[TBL] [Abstract][Full Text] [Related]
2. Tolerance induction by anti-CD2 plus anti-CD3 monoclonal antibodies: evidence for an IL-4 requirement.
Punch JD; Tono T; Qin L; Bishop DK; Bromberg JS
J Immunol; 1998 Aug; 161(3):1156-62. PubMed ID: 9686574
[TBL] [Abstract][Full Text] [Related]
3. Anti-CD2 and anti-CD3 monoclonal antibodies synergize to prolong allograft survival with decreased side effects.
Chavin KD; Qin L; Lin J; Kaplan AJ; Bromberg JS
Transplantation; 1993 Apr; 55(4):901-8. PubMed ID: 8097344
[TBL] [Abstract][Full Text] [Related]
4. Anti-CD2 monoclonal antibodies synergize with FK506 but not with cyclosporine or rapamycin to induce tolerance.
Chavin KD; Qin L; Woodward JE; Lin J; Bromberg JS
Transplantation; 1994 Mar; 57(5):736-40. PubMed ID: 7511258
[TBL] [Abstract][Full Text] [Related]
5. Anti-CD4 monoclonal antibody-induced tolerance to MHC-incompatible cardiac allografts maintained by CD4+ suppressor T cells that are not dependent upon IL-4.
Hall BM; Fava L; Chen J; Plain KM; Boyd RA; Spicer ST; Berger MF
J Immunol; 1998 Nov; 161(10):5147-56. PubMed ID: 9820484
[TBL] [Abstract][Full Text] [Related]
6. Induction of operational tolerance and generation of regulatory cells after intratracheal delivery of alloantigen combined with nondepleting anti-CD4 monoclonal antibody.
Aramaki O; Shirasugi N; Akiyama Y; Takayama T; Shimazu M; Kitajima M; Ikeda Y; Niimi M
Transplantation; 2003 Nov; 76(9):1305-14. PubMed ID: 14627908
[TBL] [Abstract][Full Text] [Related]
7. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model.
Ito H; Hamano K; Fukumoto T; Wood KJ; Esato K
J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564
[TBL] [Abstract][Full Text] [Related]
8. A potential immunosuppressive effect of anti-lymphocyte function-associated antigen-1 monoclonal antibody on islet transplantation.
Gotoh M; Fukuzaki T; Monden M; Dono K; Kanai T; Yagita H; Okumura K; Mori T
Transplantation; 1994 Jan; 57(1):123-6. PubMed ID: 7904780
[TBL] [Abstract][Full Text] [Related]
9. Treatment of rat hemiparkinson model with xenogeneic neural transplantation: tolerance induction by anti-T-cell antibodies.
Okura Y; Tanaka R; Ono K; Yoshida S; Tanuma N; Matsumoto Y
J Neurosci Res; 1997 Jun; 48(5):385-96. PubMed ID: 9185663
[TBL] [Abstract][Full Text] [Related]
10. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells.
Otomo N; Motoyama K; Yu S; Shimizu Y; Margenthaler J; Tu F; Flye MW
Surgery; 2000 Aug; 128(2):206-12. PubMed ID: 10922993
[TBL] [Abstract][Full Text] [Related]
11. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
Cai Y; Tang XD; Zhou PJ
Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
[TBL] [Abstract][Full Text] [Related]
12. Tolerance induction in a fully allogeneic combination using anti-T cell receptor-alpha beta monoclonal antibody, low dose irradiation, and donor bone marrow transfusion.
Nomoto K; Yung-Yun K; Omoto K; Umesue M; Murakami Y; Matsuzaki G; Nomoto K
Transplantation; 1995 Feb; 59(3):395-401. PubMed ID: 7871570
[TBL] [Abstract][Full Text] [Related]
13. Induction of "infectious" tolerance to MHC-incompatible cardiac allografts in CD4 monoclonal antibody-treated sensitized rat recipients.
Onodera K; Lehmann M; Akalin E; Volk HD; Sayegh MH; Kupiec-Weglinski JW
J Immunol; 1996 Sep; 157(5):1944-50. PubMed ID: 8757313
[TBL] [Abstract][Full Text] [Related]
14. Anti-CD2 monoclonal antibody-induced receptor changes. II. Interaction of CD2 and CD3.
Lin J; Chavin KD; Qin L; Ding Y; Bromberg JS
Cell Immunol; 1996 Feb; 167(2):249-58. PubMed ID: 8603434
[TBL] [Abstract][Full Text] [Related]
15. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.
Nanji SA; Hancock WW; Luo B; Schur CD; Pawlick RL; Zhu LF; Anderson CC; Shapiro AM
Diabetes; 2006 Jan; 55(1):27-33. PubMed ID: 16380473
[TBL] [Abstract][Full Text] [Related]
16. Anti-CD2 monoclonal antibodies synergize with anti-CD3 to prolong allograft survival and decrease cytokine production.
Chavin KD; Qin L; Lin J; Kaplan AJ; Bromberg JS
Transplant Proc; 1993 Feb; 25(1 Pt 1):823-4. PubMed ID: 8094913
[No Abstract] [Full Text] [Related]
17. CD27/CD70, CD134/CD134 ligand, and CD30/CD153 pathways are independently essential for generation of regulatory cells after intratracheal delivery of alloantigen.
Aramaki O; Shirasugi N; Akiyama Y; Shibutani S; Takayama T; Shimazu M; Kitajima M; Ikeda Y; Okumura K; Yagita H; Niimi M
Transplantation; 2003 Sep; 76(5):772-6. PubMed ID: 14501851
[TBL] [Abstract][Full Text] [Related]
18. Adoptive transfer of transplantation tolerance mediated by CD4+CD25+ and CD8+CD28- regulatory T cells induced by anti-donor-specific T-cell vaccination.
Wang J; Zhang L; Tang J; Jiang S; Wang X
Transplant Proc; 2008 Jun; 40(5):1612-7. PubMed ID: 18589160
[TBL] [Abstract][Full Text] [Related]
19. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.
Bolhuis RL; Roozemond RC; van de Griend RJ
J Immunol; 1986 Jun; 136(11):3939-44. PubMed ID: 3084649
[TBL] [Abstract][Full Text] [Related]
20. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]